Literature DB >> 24990207

Cost-effectiveness of selective neck dissection versus modified radical neck dissection for treating metastases in patients with oral cavity cancer: A modelling study.

Tim M Govers1, Sejal Patel1, Robert P Takes2, Thijs Merkx3, Maroeska Rovers1,4, Janneke Grutters1,4.   

Abstract

BACKGROUND: Choosing between a more or less extensive neck dissection implies a tradeoff between survival, quality of life, and costs. The purpose of this study was to determine if selective neck dissection (level I-III or I-IV) is cost-effective compared with modified radical neck dissection (level I-V) in patients with cT1-2 oral squamous cell carcinoma (OSCC) with singular nodal disease confined to level I or II.
METHODS: A decision-analytic model was developed to model quality-adjusted life years (QALYs) and costs over a lifetime horizon, based on literature.
RESULTS: The selective neck dissection strategy resulted in an expected health loss of 0.06 QALY and savings of €1351 per patient compared to modified radical neck dissection. The results were sensitive to differences in regional failure probabilities between the strategies.
CONCLUSION: With the evidence used in this model, selective neck dissection was not cost-effective compared to modified radical neck dissection. Prospective research on regional failure is needed to provide optimal treatment for patients with OSCC.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  cost effectiveness; decision support techniques; head and neck neoplasms; mouth neoplasms; neck dissection

Mesh:

Year:  2015        PMID: 24990207     DOI: 10.1002/hed.23833

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  3 in total

1.  Cost-effectiveness of computed tomography nodal scan in patients with papillary thyroid carcinoma.

Authors:  Zaid Al-Qurayshi; Gregory W Randolph; Emad Kandil
Journal:  Oral Oncol       Date:  2021-05-13       Impact factor: 5.972

2.  Comparison of CT, MRI, and F-18 FDG PET/CT for initial N-staging of oral squamous cell carcinoma: a cost-effectiveness analysis.

Authors:  Egon Burian; Benjamin Palla; Nicholas Callahan; Thomas Pyka; Constantin Wolff; Claudio E von Schacky; Annabelle Schmid; Matthias F Froelich; Johannes Rübenthaler; Marcus R Makowski; Felix G Gassert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-05-24       Impact factor: 10.057

Review 3.  Towards early and broad evaluation of innovative surgical devices: integrating evidence synthesis, stakeholder involvement, and health economic modeling into the clinical research stages of the IDEAL framework.

Authors:  Mirre Scholte; Kas Woudstra; Janneke P C Grutters; Gerjon Hannink; Marcia Tummers; Rob P B Reuzel; Maroeska M Rovers
Journal:  BMJ Surg Interv Health Technol       Date:  2022-09-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.